Human HIV-1 Monoclonal Antibody | anti-HIV-1 antibody

HIV-1 (CD4bs (gp120)) Human Monoclonal Antibody (654-30D)

Cat. Num. AAA588170

• Reactivity: HIV-1
• Applications: ELISA, Neutralization Assay, Flow Cytometry, Functional Assay
• Synonyms: HIV-1; Monoclonal Antibody; HIV-1 (CD4bs (gp120)) Human Monoclonal Antibody (654-30D); anti-HIV-1 antibody

• Host: Human
• Reactivity: HIV-1
• Clonality: Monoclonal
• Isotype: IgG1 lambda
• Clone Number: 654-30D
• Specificity: The antibody recognizes the CD4 binding domain of the HIV-1 protein gp120.
• Form/Format: Lyophilized protein G purified in PBS pH7.4

• Applicable Applications for anti-HIV-1 antibody: ELISA (EIA), Neutralization, Flow Cytometry (FC/FACS)
• Immunogen: This antibody was generated from HIV-infected individuals by a method based on the Epstein-Barr virus transformation of peripheral blood mononuclear cells (PBMCs) followed by fusion with heteromyeloma cells. The epitope for this antibody is discontinuous.
• Preservative: None
• Preparation and Storage: Lyophilized antibody can be kept at 4 degree C for up to 3 months and should be kept at-20 degree C for long-term storage.; To avoid freeze-thaw cycles, reconstituted antibody should be aliquoted before freezing for short-term storage (-20 degree C) or for long-term storage (-80 degree C).; For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.

Related Product Information for anti-HIV-1 antibody

Of the two types of Human immunodeficiency virus (HIV) which have been characterized, HIV-1 is more infective and is prevalent globally. The HIV virion is encapsulated by a viral envelope that contains complexes of surface proteins including glycoprotein 120 (gp120), which are important for the virus to attach and fuse to infect target cells. The glycoprotein CD4 (cluster of differentiation 4), found on the surface of T-cells, interacts with gp120 and cytokine receptors to mediate the entry of the virus into cells. This antibody, 654-30D, has been shown to neutralize HIV-1.

References

1. Li L-Different pattern of immunoglobulin gene usage by HIV-1 compared to non-HIV-1 antibodies derived from the same infected subject. 2. Gorny MK-Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates. 3. Jeffs SA-Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1 (IIIB) gp120. 4. Gorny MK-Effects of oligomerization on the epitopes of the human immunodeficiency virus type 1 envelope glycoproteins. 5. Nyambi PN-Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M. 6. Gorny MK-A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 clades. 7. Nyambi PN-Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness. 8. Hioe CE-Neutralization of HIV-1 primary isolates by polyclonal and monoclonal human antibodies. 9. Gorny MK-Human monoclonal antibodies to the V3 loop of HIV-1 with intra-and interclade cross-reactivity. 10. Stamatatos L-Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1. 11. Zolla-Pazner S-Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry. 12. Laal S-Synergistic neutralization of human immunodeficiency virus type 1 by combinations of human monoclonal antibodies. 13. Gorny MK-Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1.